ELI LILLY & Co — Director's Dealing 2020

Sep 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2020-09-01

Reporting Person: Mason Michael B (Sr. VP & Pres., Lilly Diabetes)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-01	Common Stock	M	6244	—	Acquired	21279	Direct
2020-09-01	Common Stock	F	2735	$148.39	Disposed	18544	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-01	Restricted Stock Unit	$	M	6244	Disposed	2020-09-01	Common Stock (6244.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	705	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.